4503.T: Astellas Pharma Inc. Stock Live Price Graph
About the company
Astellas Pharma Inc., a venerable Japanese pharmaceutical enterprise established in 1923 and headquartered in Tokyo, operates globally in the research, development, manufacturing, and commercialization of a diverse range of medications. Its extensive product lineup addresses critical health needs, including various oncology treatments such as XTANDI for prostate cancer, XOSPATA, an FLT3 inhibitor for specific relapsed or refractory acute myeloid leukemia, and PADCEV for advanced urothelial cancer. For urological conditions, Astellas offers Betanis/Myrbetriq/BETMIGA to manage symptoms of overactive bladder, mirabegron for neurogenic detrusor overactivity in children, and Vesicare for OAB. Other notable pharmaceuticals include Eligard for prostate cancer, Harnal/Omnic for benign prostatic hyperplasia, Evrenzo for anemia associated with chronic kidney disease, and the immunosuppressants Prograf/Advagraf/Graceptor/ASTAGRAF, vital for preventing organ transplant rejection. The company also markets Funguard/MYCAMINE, an antifungal agent. Astellas actively fosters innovation through numerous strategic collaborations and partnerships. These include clinical trial agreements with pharmaceutical giants like Merck & Co., Inc. and CytomX Therapeutics, Inc. Demonstrating a broader approach to health, they collaborate with BANDAI NAMCO Entertainment Inc. on developing a smartphone exercise support application. In the realm of scientific discovery, Astellas maintains a research alliance with Harvard University for joint therapeutic and technological advancements. Further research initiatives involve Actinium Pharmaceuticals, Inc. to advance targeted radiotherapies leveraging their Antibody Warhead Enabling platform, an agreement with Zenith Epigenetics Ltd. to evaluate ZEN-3694, and a collaboration with Cytokinetics, Incorporated. A significant strategic alliance and license agreement exist with Minovia Therapeutics Ltd. to research, develop, and commercialize cell therapies for mitochondrial dysfunction.
Company profile
Market News & Analysis
Target Price
No analyst target price data is available for this instrument.
Dividend History
Cash dividends
| Payment | Gross / share | Net / share | Yield | Per 1,000 TRY |
|---|---|---|---|---|
| - | $40 | $40 | 3.73% | - |
| - | $40 | $40 | 3.68% | - |
| - | $39 | $39 | 3.05% | - |
| - | $39 | $39 | 4.75% | - |
| - | $37 | $37 | 5.01% | - |
| - | $37 | $37 | 4.21% | - |
| - | $35 | $35 | 4.31% | - |
| - | $35 | $35 | 3.11% | - |
| - | $30 | $30 | 3.19% | - |
| - | $30 | $30 | 2.89% | - |
| - | $25 | $25 | 2.56% | - |
| - | $25 | $25 | 2.50% | - |
| - | $21 | $21 | 2.43% | - |
| - | $21 | $21 | 2.56% | - |
| - | $20 | $20 | 2.32% | - |
| - | $20 | $20 | 2.54% | - |
| - | $19 | $19 | 2.24% | - |
| - | $19 | $19 | 1.88% | - |
| - | $18 | $18 | 2.26% | - |
| - | $18 | $18 | 2.46% | - |
| - | $17 | $17 | 2.26% | - |
| - | $17 | $17 | 2.07% | - |
| - | $16 | $16 | 2.08% | - |
| - | $16 | $16 | 1.99% | - |
| - | $16 | $16 | 1.54% | - |
| - | $14 | $14 | 1.74% | - |
| - | $70 | $70 | 2.22% | - |
| - | $65 | $65 | 2.61% | - |
| - | $65 | $65 | 2.56% | - |
| - | $65 | $65 | 3.27% | - |
| - | $65 | $65 | 3.67% | - |
| - | $60 | $60 | 4.29% | - |
| - | $65 | $65 | 4.15% | - |
| - | $60 | $60 | 4.12% | - |
| - | $65 | $65 | 3.74% | - |
| - | $60 | $60 | 3.32% | - |
| - | $60 | $60 | 3.73% | - |
| - | $60 | $60 | 2.68% | - |
| - | $60 | $60 | 2.74% | - |
| - | $50 | $50 | 1.65% | - |
| - | $40 | $40 | 1.59% | - |
| - | $40 | $40 | 1.74% | - |
| - | $40 | $40 | 1.54% | - |
| - | $30 | $30 | 1.09% | - |
| - | $16 | $16 | 0.86% | - |
| - | $15 | $15 | 0.84% | - |
| - | $16 | $16 | 0.87% | - |
| - | $15 | $15 | 0.77% | - |
| - | $10 | $10 | 0.62% | - |
| - | $10 | $10 | 0.77% | - |
| - | $10 | $10 | 0.60% | - |
| - | $10 | $10 | 0.76% | - |
| - | $15 | $15 | 0.76% | - |
| - | $10 | $10 | 0.76% | - |
| - | $15 | $15 | 0.46% | - |
What Is 4503.T? Live 4503.T Prices and Analysis
The stock symbol 4503.T represents Takeda Pharmaceutical Company Limited, a global, research and development-driven pharmaceutical company headquartered in Japan. Established in 1781, Takeda has grown to become one of the largest pharmaceutical companies in the world, focusing on areas such as oncology, gastroenterology, neuroscience, and rare diseases. Investors closely follow Takeda due to its significant role in the pharmaceutical sector and its potential for growth through innovative drug development and strategic acquisitions.
As a publicly traded company, the performance of Takeda’s stock can be influenced by various factors, including its earnings reports, dividend announcements, and overall market sentiment. Understanding the dynamics of 4503.T is essential for investors looking to make informed decisions in the healthcare sector.
Market Context
The pharmaceutical industry operates on a global scale, with international trading affecting stock prices. Takeda, being a major player in this sector, is impacted by currency fluctuations, regulatory changes, and market volatility. The pricing currency for 4503.T is the Japanese Yen (JPY), and its stock performance can be influenced by both domestic and international economic conditions.
Why Do 4503.T Prices Rise or Fall?
The price of 4503.T can fluctuate due to a myriad of factors that investors must consider. Understanding these factors can provide insights into potential price movements and investment opportunities.
- Earnings Reports: Quarterly and annual earnings can significantly impact stock prices, especially if results exceed or fall short of market expectations.
- Drug Approvals: The success or failure of drug candidates in clinical trials can lead to substantial price changes.
- Market Sentiment: Investor perception of the pharmaceutical industry and Takeda’s position within it can drive stock prices up or down.
- Regulatory Changes: New regulations or changes in healthcare policies can affect operational costs and profitability.
- Competitive Landscape: The emergence of new competitors or advancements in rival companies can impact Takeda’s market share.
- Economic Indicators: Macroeconomic data such as GDP growth, unemployment rates, and consumer spending can influence overall market conditions.
- Dividends: Announcements regarding dividend payments or changes can attract or deter investors.
- Global Events: Situations like pandemics, trade wars, or geopolitical tensions can create market volatility.
In summary, the price of 4503.T is influenced by both internal and external factors, making it essential for investors to stay informed about company developments and broader market trends.
Why Is Live 4503.T Price Tracking Important?
Tracking the live price of 4503.T is critical for investors seeking to make timely and informed trading decisions. Real-time data allows investors to monitor stock movements and react to market changes quickly.
- Informed Decision-Making: Access to live prices helps investors analyze market trends and make strategic investment choices.
- Risk Management: Understanding price fluctuations can aid in managing investment risks effectively.
- Market Timing: Live price data enables investors to identify optimal entry and exit points for trades.
- Investment Strategies: Real-time tracking supports the implementation of various trading strategies, such as day trading or long-term investing.
- Market Sentiment: Observing price changes can provide insights into overall market sentiment towards Takeda and the pharmaceutical sector.
What Should You Consider When Trading / Investing in 4503.T?
When considering trading or investing in 4503.T, several factors warrant attention to ensure a comprehensive understanding of the potential risks and rewards.
- Volatility: The pharmaceutical sector can be highly volatile, influenced by news, drug approvals, and market trends.
- Regulatory Risks: Changes in healthcare regulations can impact Takeda’s operations and profitability.
- Market Conditions: Broader economic conditions can affect stock performance, necessitating an understanding of macroeconomic indicators.
- Company Fundamentals: Investors should analyze Takeda’s financial health, including its earnings, debt levels, and cash flow.
- Sector Trends: Awareness of trends within the pharmaceutical industry can provide context for investing in Takeda.
- Long-Term vs. Short-Term: Define your investment strategy—whether you are looking for long-term growth or short-term gains.
What Can You Find on the Investvio 4503.T Page?
- Live Price: Real-time stock price updates for 4503.T.
- Charts: Interactive charts displaying historical price movements.
- Technical Analysis: Insights into stock trends and potential future movements.
- News: Latest news and updates regarding Takeda and the pharmaceutical industry.
- Earnings Reports: Access to financial statements and earnings call transcripts.
- Market Sentiment: Analysis of investor sentiment and market trends.
In conclusion, staying informed about the live price and related market data for 4503.T is crucial for investors. The Investvio platform provides essential tools and information to empower investors in their decision-making processes regarding Takeda Pharmaceutical Company Limited.